About Soufflé Therapeutics
Founded and led by some of the greatest minds in genetic medicine, Soufflé has brought together a team of experts who share a passion for the relentless pursuit of safer, stronger and more durable medicines.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Watertown, United States
Team Size
51-100
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
souffletx.com
Domain Registered Date
Aug 20, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $135,000,000 · Series-B+
endpoints.news
- Capital Raise
Raised $200,000,000 · Series-A
fundraisingfox.com
- Milestone
Website domain registered
souffletx.com
Investors & Backers
AbbVie
Amgen
ARCH Venture Partners
Balyasny Asset Management
BB Biotech
Bessemer Venture Partners
Breyer Capital
Fidelity
Invus
Janus Henderson Investors
Juvia Group
Leaps by Bayer
Polaris
Safar Partners
TAS Partners
TCG Crossover
Temasek
Vida Ventures
Funding History
Series-B+
· Oct 13, 2026
$135,000,000 endpoints.news
Series-A
· Oct 13, 2025
$200,000,000 fundraisingfox.com
Founders & Leadership
Amir Nashat
Chief Executive Officer
Work email & phone locked
Unlock →
Bradley Pentelute
Founder
Work email & phone locked
Unlock →
Daniel Anderson
Founder
Work email & phone locked
Unlock →
Marino Zerial
Founder
Work email & phone locked
Unlock →
Robert Langer
Founder
Work email & phone locked
Unlock →
Victor Kotelianski
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026